Schuhmacher Joachim, Zimmer Dieter, Tesche Frank, Pickard Volker
Preclinical Pharmacokinetics, Pharma Research Center, Bayer AG, 42096 Wuppertal, Germany.
Rapid Commun Mass Spectrom. 2003;17(17):1950-7. doi: 10.1002/rcm.1139.
Some cases of occurrence of matrix effects (mostly ion suppression) in protein-precipitated plasma samples, and their influence on the validity of plasma concentrations and pharmacokinetic parameters, are discussed. The comparison of matrix effects using either electrospray (TurboIonspray, TISP) or atmospheric pressure chemical ionization (APCI) indicated that APCI is less prone to matrix effects. Nevertheless, TISP is usually the first choice of ionization technique since unknown thermally labile metabolites might be present in the plasma samples causing erroneous results. A high impact of ion suppression on the plasma concentrations after intravenous (i.v.) administration was found, depending on the drug formulation (vehicle). Since ion suppression caused significantly lower plasma concentrations (by a factor of up to 5.5) after i.v. dosing, the area under the curve (AUC) was underestimated and the plasma clearance was consequently erroneously high, with an impact on drug candidate selection. By simple stepwise dilution (e.g. 10-fold and 50-fold) of the supernatant of protein-precipitated plasma samples, including all calibration and quality control samples, the matrix effects were recognized and eliminated.
本文讨论了蛋白质沉淀血浆样品中基质效应(主要是离子抑制)的一些发生情况,以及它们对血浆浓度和药代动力学参数有效性的影响。使用电喷雾(TurboIonspray,TISP)或大气压化学电离(APCI)对基质效应进行比较,结果表明APCI不易受到基质效应的影响。然而,TISP通常是电离技术的首选,因为血浆样品中可能存在未知的热不稳定代谢物,从而导致错误的结果。研究发现,离子抑制对静脉注射(i.v.)给药后的血浆浓度有很大影响,这取决于药物制剂(载体)。由于离子抑制在静脉给药后导致血浆浓度显著降低(高达5.5倍),曲线下面积(AUC)被低估,血浆清除率因此错误地升高,这对候选药物的选择产生了影响。通过对蛋白质沉淀血浆样品的上清液进行简单的逐步稀释(例如10倍和50倍),包括所有校准和质量控制样品,基质效应得以识别和消除。